Medical Journals

Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic Beta Cell Growth and Function.

Authors:
  • Park Sunmin
  • Dong Xiaocheng
  • Fisher Tracy L
  • Dunn Sarah
  • Omer A Kadir
  • Weir Gordon
  • White Morris F

From: Howard Hughes Medical Institute, Division of Endocrinology, Department of Medicine, Children’s Hospital Boston, MA 02215, USA.

The Journal of biological chemistry

  • Publish Date: Jan 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 2
  • Pages: 1159-68
  • Medium: Print
  • Language: English
  • Citation (JAMA): Park Sunmin, Dong Xiaocheng, Fisher Tracy L, et al. Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic Beta Cell Growth and Function.. J. Biol. Chem. Jan 2006;281:1159-68

Abstract

The insulin receptor substrate 2 (Irs2) branch of the insulin/insulin-like growth factor-signaling cascade prevents diabetes in mice because it promotes beta cell replication, function, and survival, especially during metabolic stress. Because exendin-4 (Ex4), a long acting glucagon-like peptide 1 receptor agonist, has similar effects upon beta cells in rodents and humans, we investigated whether Irs2 signaling was required for Ex4 action in isolated beta cells and in Irs2(-/-) mice. Ex4 increased cAMP levels in human islets and Min6 cells, which promoted Irs2 expression and stimulated Akt phosphorylation. In wild type mice Ex4 administered continuously for 28 days increased beta cell mass 2-fold. By contrast, Ex4 failed to arrest the progressive beta cell loss in Irs2(-/-) mice, which culminated in fatal diabetes; however, Ex4 delayed the progression of diabetes by 3 weeks by promoting insulin secretion from the remaining islets. We conclude that some short term therapeutic effects of glucagon-like peptide 1 receptor agonists can be independent of Irs2, but its long term effects upon beta cell growth and survival are mediated by the Irs2 branch of the insulin/insulin-like growth factor signaling cascade.

Mesh Headings (Keywords): Animals, Blood Glucose, Cell Line, Cell Survival, Cyclic AMP, Dose-Response Relationship, Drug, Electrophoresis, Polyacrylamide Gel, Genotype, Glucose, Guinea Pigs, Humans, Hyperglycemia, Immunoblotting, Immunohistochemistry, Immunoprecipitation, Insulin, Insulin-Secreting Cells, Intracellular Signaling Peptides and Proteins, Islets of Langerhans, Mice, Mice, Transgenic, Models, Biological, Models, Chemical, Pancreas, Peptides, Phosphoproteins, Phosphorylation, RNA, Messenger, RNA, Small Interfering, Receptor, Insulin, Receptors, Glucagon, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Time Factors, Venoms


Check for Full Text / PubMed Unique Identifier (PMID): 16272563


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.